Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127912501 | 12791250 | 1 | I | 20160830 | 20160927 | 20160929 | 20160929 | EXP | FR-ROCHE-1835654 | ROCHE | 62.00 | YR | M | Y | 0.00000 | 20160929 | MD | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127912501 | 12791250 | 1 | PS | Rocephine | CEFTRIAXONE SODIUM | 1 | Unknown | U | 63239 | ||||||||||
127912501 | 12791250 | 2 | SS | ZYTIGA | ABIRATERONE ACETATE | 1 | Oral | U | 0 | ||||||||||
127912501 | 12791250 | 3 | SS | ZYTIGA | ABIRATERONE ACETATE | 1 | Oral | U | 0 | ||||||||||
127912501 | 12791250 | 4 | SS | PRIMPERAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Oral | U | 0 | ||||||||||
127912501 | 12791250 | 5 | SS | DITROPAN | OXYBUTYNIN CHLORIDE | 1 | Oral | U | 0 | ||||||||||
127912501 | 12791250 | 6 | SS | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | U | 0 | 1 | G | ||||||||
127912501 | 12791250 | 7 | SS | INEXIUM | ESOMEPRAZOLE | 1 | Oral | U | 0 | 40 | MG | QD | |||||||
127912501 | 12791250 | 8 | SS | THERALENE (FRANCE) | TRIMEPRAZINE | 1 | Oral | U | 0 | 20 | GTT | ||||||||
127912501 | 12791250 | 9 | SS | ACUPAN | NEFOPAM HYDROCHLORIDE | 1 | Oral | U | 0 | ||||||||||
127912501 | 12791250 | 10 | C | PRETERAX | INDAPAMIDEPERINDOPRIL | 1 | 0 | ||||||||||||
127912501 | 12791250 | 11 | C | DIFFU K | POTASSIUM CHLORIDE | 1 | 0 | ||||||||||||
127912501 | 12791250 | 12 | C | FLAGYL | METRONIDAZOLEMETRONIDAZOLE HYDROCHLORIDE | 1 | 0 | ||||||||||||
127912501 | 12791250 | 13 | C | FLUIMUCIL | ACETYLCYSTEINE | 1 | 0 | ||||||||||||
127912501 | 12791250 | 14 | C | PREDNISOLONE. | PREDNISOLONE | 1 | 0 | ||||||||||||
127912501 | 12791250 | 15 | C | TAXOTERE | DOCETAXEL | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127912501 | 12791250 | 1 | Product used for unknown indication |
127912501 | 12791250 | 2 | Prostate cancer |
127912501 | 12791250 | 4 | Product used for unknown indication |
127912501 | 12791250 | 5 | Product used for unknown indication |
127912501 | 12791250 | 6 | Product used for unknown indication |
127912501 | 12791250 | 7 | Product used for unknown indication |
127912501 | 12791250 | 8 | Product used for unknown indication |
127912501 | 12791250 | 9 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127912501 | 12791250 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127912501 | 12791250 | Hepatitis | |
127912501 | 12791250 | Renal failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127912501 | 12791250 | 1 | 20160830 | 201609 | 0 | |
127912501 | 12791250 | 2 | 20160308 | 201603 | 0 | |
127912501 | 12791250 | 3 | 20160801 | 201609 | 0 | |
127912501 | 12791250 | 4 | 201609 | 0 | ||
127912501 | 12791250 | 5 | 201609 | 0 | ||
127912501 | 12791250 | 6 | 201609 | 0 | ||
127912501 | 12791250 | 7 | 201609 | 0 | ||
127912501 | 12791250 | 8 | 201609 | 0 | ||
127912501 | 12791250 | 9 | 201609 | 0 |